# Comparative Effectiveness of Metformin for Type 2 Diabetes With Chronic Kidney Disease

> **NCT03921242** · — · COMPLETED · sponsor: **Weill Medical College of Cornell University** · enrollment: 4888 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2
- Renal Insufficiency, Chronic

## Interventions

- **DRUG:** Metformin
- **DRUG:** Sulfonylurea
- **DRUG:** DPP-4 inhibitor
- **DRUG:** SGLT2 inhibitor
- **DRUG:** GLP1 receptor agonist

## Key facts

- **NCT ID:** NCT03921242
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-01
- **Primary completion:** 2023-08-01
- **Final completion:** 2023-08-01
- **Target enrollment:** 4888 (ACTUAL)
- **Last updated:** 2023-11-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03921242

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03921242, "Comparative Effectiveness of Metformin for Type 2 Diabetes With Chronic Kidney Disease". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03921242. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*